June 04, 2020 11:34 pm
Transasia is first Indian company to get ELISA kit approved in country. In May, ICMR developed the technology for ELISA in National Institute of Virology, Pune, and transferred the technology to Zydus Cadilla for mass production of kits.
June 04, 2020 9:16 am
It is time the government, technical experts and private companies ensure that these researchers have access to the resources and tools that can make India truly atmanirbhar.
June 03, 2020 3:03 pm
The asymptomatic patients are discharged after 10 days and sent to home isolation, in accordance with the revised ICMR guidelines which do not make it mandatory to conduct the test at the time of discharge.
June 04, 2020 9:46 am
The ICMR has said that the country is still “very far away from the peak”. Over the last few days, over 8,000 new cases have been reported from across the country daily.
May 23, 2020 1:11 am
According to experts, this therapy involves taking antibodies from the blood of a person who has recovered from Covid-19 and transfusing those antibodies into an active coronavirus patient, to help kick-start the immune system to fight the infection.
May 20, 2020 9:22 pm
The centre of excellence will aim to develop marketable technologies within a time frame and use this experience to achieve longer-term goals to address challenging problems in the field of medical devices and diagnostics.
May 19, 2020 7:49 am
The ICMR has specified that “no emergency procedure (including deliveries) should be delayed for lack of test.” If a patient fits the testing criteria, his/ her test can be done simultaneously with the emergency procedure.
May 15, 2020 10:35 am
The coronavirus test kits, called “COVID KAVACH ELISA”, was developed at the National Institute of Virology, Pune, by isolating the virus from patients in India earlier this week.
May 09, 2020 6:21 am
The move comes after ICMR, on April 13, issued a tender asking central PSUs to act as procurement agencies for essential supplies related to COVID-19 testing.
May 08, 2020 1:11 pm
“Due to missing information, the department is unable to trace patients and their contacts in a timely manner to complete the surveillance process. The matter has been highlighted several times during the meeting with the Ministry officials," an official said.